Early weight loss of 2%-3% within 4 weeks is significantly linked to achieving clinically significant weight loss at 16 weeks ...

As more Americans turn to weight loss drugs, the U.S. adult obesity rate​ is declining, according to new survey data from ...

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

Experts recommend eating foods high in probiotics before taking a supplement for weight loss, but supplements can help fill ...

Plus, the Trump administration is expected to release finalized Medicare payment rules for doctors and hospitals as soon as ...

Celebrities open up about using Ozempic and weight loss injections, sharing their stories, results, and side effects ...

Amy Schumer has candidly opened up on the debilitating side effect she suffered while she was on Ozempic. The 43-year-old ...

Adults with obesity lose more weight with semaglutide than with placebo (a sham medication). However, the risk of unwanted events is probably higher than with placebo after 24 months. Semaglutide ...

The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity ...

Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...